Table 1.

Correlation between G3BP1 expression and clinicopathological characteristics in patients with GC

Parameters	No.	G3BP1		P-value
High (n=81)	Low (n=39)
Gender				0.581
Male	78	54 (66.7%)	24 (61.5%)
Female	42	27 (33.3%)	15 (38.5%)
Age				0.133
<60 y	58	43 (53.1%)	15 (38.5%)
≥60 y	62	38 (46.9%)	24 (61.5%)
Tumor location				0.721
Cardiac	19	14 (17.3%)	5 (12.8%)
Body	30	21 (25.9%)	9 (23.1%)
Pylorus	71	46 (56.8%)	25 (64.1%)
Tumor differentiation				0.678
Well	10	8 (9.9%)	2 (5.1%)
Moderate	18	12 (14.8%)	6 (15.4%)
Poor	92	61 (75.3%)	31 (79.5%)
Lauren classification				0.320
Intestinal Type	65	41 (50.6%)	24 (61.5%)
Diffused Type	51	38 (46.9%)	13 (33.3%)
Mixed Type	4	2 (2.5%)	2 (5.1%)
T				0.018
T1+T2	39	32 (39.5%)	7 (17.9%)
T3+T4	81	49 (60.5%)	32 (82.1%)
N				0.009
N0	48	39 (48.1%)	9 (23.1%)
N1-N3	72	42 (51.9%)	30 (76.9%)
M				0.016
M0	99	63 (76.8%)	36 (94.7%)
M1	21	19 (23.2%)	2 (5.3%)
TNM stages				0.005
I-II	59	47 (58%)	12 (30.8%)
III-IV	61	34 (42%)	27 (69.2%)

Note: Bold indicates statistical significance at P<0.05.